Patents

Company announces issuance of second Cardiosonix patent

Published in Medical Letter on the CDC and FDA, May 16th, 2004

Neoprobe Corp. (NEOP), a diversified developer of oncology and cardiovascular surgical and diagnostic products, announced that notification was received from the U.S. Patent and Trademark Office regarding the issuance of the second patent (U.S. patent #6,719,698) covering the products of its subsidiary, Cardiosonix, Ltd., (Cardiosonix).

This second patent covers key aspects of the ADBF technology as well as innovations and enhancements to the Quantix family of products for the measurement of blood flow in a variety of clinical applications that are also protected by U.S. patent #6,503,205.

Additional patents covering the Cardiosonix technology are...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2004-05-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry